Psychopharmacology of Child and Adolescent Major Depression: Present Status and Future Directions
- 1 January 1992
- journal article
- Published by Mary Ann Liebert Inc in Journal of Child and Adolescent Psychopharmacology
- Vol. 2 (1) , 31-45
- https://doi.org/10.1089/cap.1992.2.31
Abstract
Current concerns about antidepressant efficacy in children and adolescents are reminiscent of the history of adult studies. Such awareness should temper these concerns, especially in view of the enormous progress in the last two decades of studies of adult depression. A number of methodologie, nosologie, developmental, and validity considerations may have hampered the child and adolescent studies to date; thus, with more careful consideration of past problem areas, future studies may yield more promising results. The next generation of treatment research in child and adolescent depression may require innovative, multisite, longitudinal treatment designs which allow the simultaneous possibility for the continuing clarification and validation of depressive syndromes and treatment-responsive subgroups.Keywords
This publication has 4 references indexed in Scilit:
- Three-Year Outcomes for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1990
- Childhood and Adolescent DepressionThe British Journal of Psychiatry, 1988
- The pharmacological treatment of delusional depressionAmerican Journal of Psychiatry, 1985
- Plasma Levels of Imipramine (IMI) and Desmethylimipramine (DMI) and Clinical Response in Prepubertal Major Depressive Disorder: A Preliminary ReportJournal of the American Academy of Child Psychiatry, 1979